Comparison of different fixed antihypertensive combination drugs: A double-blind, placebo-controlled parallel group study

Journal of Hypertension

Volumn 15, Issue 1, 1997, Pages 87-91

  De Leeuw, Peter W ^b   Notter, Thomas ^a   Zilles, Peter ^a  

^a Knoll AG   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atenolol chlorthalidone; Combination therapy; Essential hypertension; Lisinopril hydrochlorothiazide; Tolerability; Verapamil trandolapril

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; ATENOLOL PLUS CHLORTALIDONE; CHLORTALIDONE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LISINOPRIL; PLACEBO; TRANDOLAPRIL; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE FORMULATION; VERTIGO;

EID: 0031053118     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715010-00009     Document Type: Article

References (21)

1. James IM: Which antihypertensive? Br J Clin Pract 1990, 44:102-105.
2. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992, 327:685-691.
3. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992, 327:669-677.
4. Yusuf S, Held P, Furberg C: Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991, 67:1295-1297.
5. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992, 41:912-919.
6. Bakris GL: Hypertension in diabetic patients. Am J Hypertens 1993, 6:140S-147S.
7. Aursnes I, Litleskare I, Frøland H, Abdelnoor M: Association between various drugs used for hypertension and risk of acute myocardial infarction. Blood Press 1995, 4:157-163.
8. Guidelines Sub-Committee: 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organisation/ International Society of Hypertension meeting. J Hypertens 1993, 11:905-918.
9. Wiseman LR, McTavish D: Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. Drugs 1994, 48:71-90.
10. Scholze J, Zilles P, Compagnone D: Verapamil SR and trandolapril combination therapy in hypertension. A clinical trial of factorial design. Submitted for publication.
11. Brunner HR, Ménard J, Waeber B, Burnier M, Biollaz J, Nussberger J, et al.: Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990, 8:3-11.
12. Fioretto P, Frigato F, Velussi M, Riva F, Muollo A, Brocco CE, et al.: Effects of angiotensin converting enzyme inhibition and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 1992, 5:837-846.
13. Ferrier C, Ferrari P, Weidmann P, Keller U, Piccoli CB, Riesen WF: Antihypertensive therapy with Ca2+ antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients. Diabetes Care 1991, 14:911-914.
14. Remuzzi G, Ruggenenti P: Slowing the progression of diabetic nephropathy. N Engl J Med 1993, 329:1496-1497.
15. CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987, 316:1429-1435.
16. AIRE Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993, 324:821-828.
17. Mancia G, Mangoni AA, Failla M, Rivolta MR: Guidelines for the treatment of hypertension, a commentary. Curr Ther Res 1996, 57:3-13.
18. Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT: Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up. Lancet 1982, ii:1293-1295.
19. Frishman WH, Mayer HB: Beta-adrenergic blockers in hypertension: an updated review. In New Therapeutic Strategies in Hypertension. Edited by Kaplan NM, Brenner BM, Laragh JH. New York: Raven Press Ltd; 1989:71-96.
20. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kolorin I, Frohlich ED: Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 1984, 53:105-108.
21. Nakashima Y, Fouad FM, Tarazi RC: Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984, 53:1044-1049.